In the News
Russo Partners works at the intersection of science, medicine, and media. The stories below reflect the conversations we help shape covering breakthroughs in biopharma, digital health, healthcare, and beyond.
ABC 7 Chicago
|
April 14, 2026
New drug created at Northwestern helps pancreatic cancer patients live longer, oncologist says
A drug trial at Northwestern Medicine offers hopeful results to those with pancreatic cancer. GI Oncologist Dr. Deva Mahalingam is…
For more
TIME
|
April 14, 2026
Two New Drugs Offer Hope for Pancreatic Cancer
Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have…
For more
FOX 5 Las Vegas
|
April 7, 2026
Former Bengal Ickey Woods bringing celebrity golf tourney to Las Vegas for asthma charity
Former NFL player and Cincinnati Bengals fan favorite Ickey Woods is coming to Las Vegas on Monday, April 13, to…
For more
BioWorld
|
April 9, 2026
Ibio’s IBIO-600 cleared to enter clinic in Australia for obesity
Ibio Inc. has received clinical trial notification (CTN) acknowledgement from Australia’s Therapeutic Goods Administration (TGA), as well as Human Research…
For more
MedCity News
|
April 5, 2026
Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable Biologics
Startup Pinnacle Medicines is developing peptide drugs with the same efficacy as biologic medicines and the dosing convenience of oral…
For more
CFO Brew
|
March 31, 2026
Pharma CFO plans for telehealth expansion
Sam Backenroth is concocting a recipe for Aspargo Labs’ finance function. Backenroth joined the company, which develops liquid oral suspensions…
For more
The Columbian
|
March 28, 2026
Vancouver-based CytoDyn makes waves in breast cancer treatment
Four short years ago, Vancouver-based CytoDyn was embroiled in scandal. But a group of executives fought to bring the biotech…
For more
JAMA
|
March 26, 2026
FDA’s Promising New Framework for Rare Genetic Diseases
The ability to treat the underlying causes of rare genetic diseases is a new scientific achievement after many years when…
For more
Axios
|
March 26, 2026
Pinnacle Medicines raises $89M for oral peptide development
Pinnacle Medicines, developer of oral peptides for immunology and cardiometabolic diseases, raised an $89 million Series B. Oral peptide drugs…
For more
ABC (WJBF-TV)
|
March 23, 2026
Augusta Fire Dept. holds esophageal pre-cancer screenings for firefighters, staff
Firefighters face many dangers when battling a blaze, including an increased risk of certain cancers. That’s why the Augusta Fire…
For more
Upcoming Events
Our team is active across the industry year-round. Find us at these upcoming conferences and events.
